Wanee Leelalertsuphakun
Director Ejecutivo en LEE'S PHARMACEUTICAL HOLDINGS LIMITED .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de Wanee Leelalertsuphakun
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Director/Miembro de la Junta | 01/12/2001 | - |
| Director Ejecutivo | 01/04/1997 | - | |
| Ventas & Marketing | 01/09/2003 | - | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Director/Miembro de la Junta | 20/02/2017 | - |
Guangzhou Zhaokang Hospital Co., Ltd.
 Guangzhou Zhaokang Hospital Co., Ltd. Hospital/Nursing ManagementHealth Services Part of Guangzhou Haofeng Operation Management Co. Ltd., Guangzhou Zhaokang Hospital Co., Ltd. is a company that operates hospitals. Guangzhou Zhaokang Hospital Co., Ltd. is based in Guangzhou, China. Guangzhou Zhaokang Hospital Co. was acquired by Guangzhou Haofeng Operation Management Co. Ltd. from Lee's Pharmaceutical Holdings Ltd. on September 22, 2022 for $28.36 million. The Chinese company was founded in 2015. | Director/Miembro de la Junta | - | - |
Historial de carrera de Wanee Leelalertsuphakun
Estadísticas
Internacional
| China | 3 |
| Hong-Kong | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Sales & Marketing | 1 |
Sectorial
| Health Technology | 3 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
| ZHAOKE OPHTHALMOLOGY LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
Guangzhou Zhaokang Hospital Co., Ltd.
Guangzhou Zhaokang Hospital Co., Ltd. Hospital/Nursing ManagementHealth Services Part of Guangzhou Haofeng Operation Management Co. Ltd., Guangzhou Zhaokang Hospital Co., Ltd. is a company that operates hospitals. Guangzhou Zhaokang Hospital Co., Ltd. is based in Guangzhou, China. Guangzhou Zhaokang Hospital Co. was acquired by Guangzhou Haofeng Operation Management Co. Ltd. from Lee's Pharmaceutical Holdings Ltd. on September 22, 2022 for $28.36 million. The Chinese company was founded in 2015. | Health Services |
